Design, synthesis, and in vitro and in vivo evaluation of a series of antipsoriatic antedrugs having 16-en-22-oxa-vitamin D3 are described. Among the seven compounds examined, two are promising: ester 5c and amide 5f, both of which exhibit greater potent antiproliferation activity with lessened calcemic activity than the presently prescribed maxacalcitol (2).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2006.03.014 | DOI Listing |
Publication Analysis
Top Keywords
design evaluation
4
evaluation antipsoriatic
4
antipsoriatic antedrug
4
antedrug candidates
4
candidates 16-en-22-oxa-vitamin
4
16-en-22-oxa-vitamin structures
4
structures design
4
design synthesis
4
synthesis vitro
4
vitro vivo
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!